Integrative analysis of genome-wide DNA methylation and gene expression profiles associated with incident chronic kidney disease: the longitudinal Pros-RODAM cohort study
BACKGROUND: Chronic kidney disease (CKD) is increasing rapidly in African populations, yet its molecular determinants remain poorly characterised. While epigenome-wide studies have been largely confined to high-income settings, comparable longitudinal epigenetic data from African populations are scarce, despite distinct genetic and environmental contexts. We conducted a longitudinal epigenome-wide study of CKD in an African population, integrating DNA methylation and gene expression to identify epigenetic changes associated with CKD and related kidney function decline. METHODS: DNA methylation was profiled using the Illumina EPIC (850K) array in 274 Ghanaian participants from the RODAM-Prospective cohort (92 incident CKD cases and 182 matched controls), providing 548 DNA methylation observations across baseline and ∼6-year follow-up, with high-quality DNA methylation data available at both timepoints. Epigenome-wide association studies (EWAS) were performed for incident CKD, change in estimated glomerular filtration rate (ΔeGFR), and change in urinary albumin-to-creatinine ratio (ΔACR), adjusting for demographic, clinical, and technical covariates. Differentially methylated regions (DMRs) were identified using bumphunter with family-wise error rate control. Differential gene expression (RNA-seq) analyses were conducted, followed by covariate-adjusted expression quantitative trait methylation (eQTM) analyses to link methylation with gene expression. FINDINGS: At baseline, significant differentially methylated positions (DMPs) were detected at INF2 (incident CKD), CLIP4 (ΔeGFR), and TMEM109 (ΔACR), alongside DMRs at HLA-DPB1 and SH2D1B (incident CKD) and ZFP57 and OR2T11 (ΔACR). At follow-up, a progression-related DMR in C4orf39/TRIM61 (ΔACR) was identified, with recurrent signals at hypermethylated HLA-DPB1 and hypomethylated ZFP57 and OR2T11 across timepoints. Integrative eQTM analysis revealed methylation-expression associations at recurrent loci including ZFP57, HLA-DRB5, SLC39A4, and SPATC1L, with predominantly inverse associations at ZFP57, HLA-DRB5, and SLC39A4, highlighting associations with metabolic and immune regulatory pathways. INTERPRETATION: We identified epigenetic changes associated with incident CKD and kidney function decline in an African population. These methylation signals, supported by gene expression patterns, highlight immune and kidney-related pathways associated with CKD risk and progression. Our findings provide a foundation for future studies investigating the potential of epigenetic markers in CKD risk stratification and prevention in African populations. FUNDING: European Commission; European Research Council.
Authors
- Benedicta Ngwenchi Nkeh-Chungag (ORCID: https://orcid.org/0000-0003-4805-4051)
- Charles Frederick Hayfron-Benjamin (ORCID: https://orcid.org/0000-0003-0175-0340)
- Samuel Nkansah Darko (ORCID: https://orcid.org/0000-0002-0750-4311)
- Constance Rufaro Sewani-Rusike (ORCID: https://orcid.org/0000-0002-3295-2933)
- Felix Patience Chilunga (ORCID: https://orcid.org/0000-0003-4083-001X)
- Liffert Vogt (ORCID: https://orcid.org/0000-0002-4585-7505)
- Muhau Muhulo Mungamba (ORCID: https://orcid.org/0000-0003-3676-6924)
- Peter Henneman (ORCID: https://orcid.org/0000-0003-2179-7808)
- Charles O Agyemang (ORCID: https://orcid.org/0000-0002-3882-7295)
- Eva L. van der Linden (ORCID: https://orcid.org/0000-0002-4037-1717)
- manasa Kalya Purushothama
- Karlijn A. C. Meeks (ORCID: https://orcid.org/0000-0003-3032-405X)
- Andrea Venema
- Ellis Owusu-Dabo
- Bert-Jan van den Born
Institutions
- University of Maryland, Baltimore (US)
- University of Ghana (GH)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- Korle Bu Teaching Hospital (GH)
- Kwame Nkrumah University of Science and Technology (GH)
- Amsterdam Neuroscience (NL)
- Amsterdam Public Health (NL)
- Amsterdam University Medical Centers (NL)
- Amsterdam Reproduction Development (NL)
- Amsterdam Cardiovascular Sciences (NL)
- Amsterdam University of Applied Sciences (NL)
- University of Amsterdam (NL)
- Walter Sisulu University (ZA)
Publication Details
- Journal
- EBioMedicine
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1016/j.ebiom.2026.106542
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ernest Oppenheimer Memorial Trust